Published in Semin Thromb Hemost on October 01, 2006
Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis (Armour) | NCT01324037
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
Paget-schroetter syndrome: review of pathogenesis and treatment of effort thrombosis. West J Emerg Med (2010) 1.25
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost (2011) 1.05
Case reports: heritable thrombophilia associated with deep venous thrombosis after shoulder arthroscopy. Clin Orthop Relat Res (2009) 0.96
Deep vein thromboembolism after arthroscopy of the shoulder: two case reports and a review of the literature. BMC Musculoskelet Disord (2010) 0.94
Upper extremity deep venous thromboembolism following arthroscopic labral repair of the shoulder and biceps tenodesis: a case report. Int J Sports Phys Ther (2014) 0.81
Paget-Schrotter syndrome and complications of management. BMJ Case Rep (2013) 0.79
Risk factors for venous thrombosis associated with peripherally inserted central venous catheters. Int J Clin Exp Med (2014) 0.78
Emergency department diagnosis of upper extremity deep venous thrombosis using bedside ultrasonography. Crit Ultrasound J (2012) 0.75
Thromboembolism Following Shoulder Arthroscopy: A Retrospective Review. Orthop J Sports Med (2014) 0.75
A Case with Upper Extremity Deep Vein Thrombosis after in vitro Fertilization. J Cardiovasc Ultrasound (2010) 0.75
Hand gangrene following unsuccessful cannulation of the internal jugular vein: a case report and literature review. Hand (N Y) (2009) 0.75
Internal Jugular and Subclavian Vein Thrombosis in a Case of Ovarian Cancer. Case Rep Otolaryngol (2017) 0.75
Recurrent Upper Extremity Thrombosis Associated with Overactivity: A Case of Delayed Diagnosis of Paget-Schroetter Syndrome. Case Rep Vasc Med (2017) 0.75
Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med (2012) 10.64
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med (2004) 5.68
Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med (2010) 5.65
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med (2009) 4.27
Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet (2007) 3.66
Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Ann Intern Med (2008) 2.85
The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol (2005) 2.31
Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med (2003) 2.28
Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention. Clin Pharmacokinet (2011) 2.09
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica (2007) 2.00
Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost (2008) 1.91
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest (2006) 1.85
A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J (2004) 1.80
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation (2014) 1.64
The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med (2007) 1.63
Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost (2006) 1.57
A prospective study on survival in cancer patients with and without venous thromboembolism. Intern Emerg Med (2013) 1.42
Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. Blood (2013) 1.39
Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J (2012) 1.31
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood (2002) 1.23
Superficial vein thrombosis: risk factors, diagnosis, and treatment. Semin Thromb Hemost (2006) 1.11
Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemost (2010) 1.11
Sex and anticoagulation in patients with idiopathic venous thromboembolism. Lancet (2006) 1.11
Simplification of the diagnostic management of suspected deep vein thrombosis. Arch Intern Med (2002) 1.09
Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood (2002) 1.02
The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica (2007) 0.98
Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer. Eur J Cancer (2011) 0.97
Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica (2007) 0.93
ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfus (2012) 0.89
Cancer Screening in Unprovoked Venous Thromboembolism. N Engl J Med (2015) 0.89
Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis. Circulation (2011) 0.89
Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. Thromb Haemost (2013) 0.88
Warfarin versus low-molecular-weight heparin therapy in cancer patients. Oncologist (2005) 0.86
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study. Thromb Haemost (2015) 0.85
Thrombophilia as a predictor of persistent residual vein thrombosis. Haematologica (2008) 0.85
Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. Intern Emerg Med (2011) 0.84
Double vena cava filter insertion in congenital duplicated inferior vena cava: a case report and literature review. Haematologica (2006) 0.83
Does hemophilia protect against atherosclerosis? A case-control study. Clin Appl Thromb Hemost (2006) 0.83
The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood (2002) 0.82
Heart disease in patients with pulmonary embolism. Curr Opin Pulm Med (2010) 0.82
Long-term use of vitamin K antagonists and incidence of cancer: a population-based study. Blood (2010) 0.82
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism. Thromb Haemost (2004) 0.82
Recurrent venous thromboembolism in men and women. N Engl J Med (2004) 0.81
The postthrombotic syndrome. Intern Emerg Med (2009) 0.81
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study. Haematologica (2007) 0.80
Prevention and treatment of the post-thrombotic syndrome and of the chronic thromboembolic pulmonary hypertension. Expert Rev Cardiovasc Ther (2015) 0.80
Elastic stockings, hydroxyethylrutosides or both for the treatment of post-thrombotic syndrome. Thromb Haemost (2005) 0.80
Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost (2006) 0.80
Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests. Thromb Haemost (2014) 0.80
[Profiles of medical malpractice in the prophylaxis of pulmonary thromboembolism]. Ital Heart J Suppl (2003) 0.79
The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study. Clin Appl Thromb Hemost (2010) 0.79
Venous and arterial thrombosis: two aspects of the same disease? Eur J Intern Med (2009) 0.79
Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE registry. Haematologica (2008) 0.79
Venous thromboembolism and arterial complications. Semin Respir Crit Care Med (2012) 0.79
Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone. Am J Respir Crit Care Med (2014) 0.78
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. Thromb Haemost (2012) 0.78
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis. Thromb Haemost (2013) 0.78
Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer. Intern Emerg Med (2015) 0.78
Postthrombotic syndrome. Semin Thromb Hemost (2006) 0.77
Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey. Eur J Intern Med (2009) 0.77
Heparin- induced thrombocytopenia occurring in the first trimester of pregnancy: successful treatment with lepirudin. A case report. Haematologica (2006) 0.77
High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study. Haematologica (2002) 0.77
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. Multidiscip Respir Med (2013) 0.77
Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study. Eur J Haematol (2013) 0.77
An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia. Haematologica (2003) 0.77
Anticoagulants and cancer survival. Semin Thromb Hemost (2006) 0.77
Cancer and venous thromboembolism. Semin Thromb Hemost (2006) 0.77
Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications Associated With Acute Symptomatic Pulmonary Embolism. Chest (2015) 0.77
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies. Thromb Haemost (2016) 0.77
Safety of low molecular weight heparins in the treatment of venous thromboembolism. Expert Opin Drug Saf (2003) 0.76
Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities. Thromb Haemost (2009) 0.76
Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment. Thromb Res (2005) 0.76
Cost-effectiveness of bemiparin in the prevention and treatment of venous thromboembolism. Expert Rev Pharmacoecon Outcomes Res (2006) 0.76
Toward the simplification of antithrombotic treatment of venous thromboembolism. Ann Intern Med (2004) 0.75
New insights on the role of direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery. Thromb Haemost (2011) 0.75
Optimal duration of anticoagulation in patients with venous thromboembolism. Indian J Med Res (2011) 0.75
Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism. Curr Opin Pulm Med (2005) 0.75
VITRAIL: Acquisition, Modeling, and Rendering of Stained Glass. IEEE Trans Image Process (2016) 0.75
Lessons learned from cancer/VTE Registries: report from RIETE. Thromb Res (2007) 0.75
Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design. Thromb Haemost (2016) 0.75
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism. Semin Thromb Hemost (2006) 0.75
The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism. Blood Coagul Fibrinolysis (2015) 0.75
From acute pulmonary embolism to chronic thromboembolic pulmonary hypertension. Ital Heart J (2005) 0.75
Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry. Intern Emerg Med (2014) 0.75
Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis. Thromb Haemost (2016) 0.75
Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors. Thromb Haemost (2003) 0.75
How to effectively manage the event of bleeding complications when using anticoagulants. Expert Rev Hematol (2015) 0.75
Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score. Thromb Haemost (2016) 0.75
[Has high-definition spiral computed tomography changed the management of patients with acute pulmonary embolism?]. G Ital Cardiol (Rome) (2008) 0.75
New strategies for the treatment of acute venous thromboembolism. Semin Thromb Hemost (2006) 0.75
Failure of old and new anticoagulants to prevent ischemic stroke in high-risk atrial fibrillation: a case report. Minerva Cardioangiol (2016) 0.75
Recent venous thromboembolism amongst adult individuals attending general practitioner ambulatory (the FAST study): prevalence of cardiovascular risk factors. Thromb Res (2008) 0.75